+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti Peptic Ulcer Drugs Companies in China

  • PDF Icon

    Report

  • 54 Pages
  • February 2024
  • Region: China
  • AMID Co
  • ID: 3447642

China's demand for Anti Peptic Ulcer Drugs will continue to grow at about 7% by 2033

This study focuses on China’s Anti Peptic Ulcer Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This study analyzes the industry structure, capacities and output. Major producers' production locations, market shares and profiles are presented. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and in-house databases.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. ANTI PEPTIC ULCER DRUGS INDUSTRY ASSESSMENTS
  • Anti Peptic Ulcer Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Anti Peptic Ulcer Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers’ Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development
III. ANTI PEPTIC ULCER DRUGS PRODUCER DIRECTORY
  • Profiles of Anti Peptic Ulcer Drugs Producers and Major Consumption in Industry
LIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
II. ANTI PEPTIC ULCER DRUGS INDUSTRY ASSESSMENTS
  • Anti Peptic Ulcer Drugs Sales Volume and Market Share by Drugs Classification
  • Proton Pump Inhibitors Sales Volume and Market Share by Drugs Classification
  • H2 Receptor Antagonist Sales Volume and Market Share by Drugs Classification
  • Gastric Mucosal Protective Drugs Sales Volume and Market Share by Drugs Classification
  • Anti Peptic Ulcer Drugs Sales Volume
  • Major Producer Facility Location
  • Major Anti Peptic Ulcer Drugs Producer Sales Volume
  • Major Foreign Investment in China
LIST OF CHARTS
I. INTRODUCTION
  • Anti Peptic Ulcer Drugs Sales Volume
II. ANTI PEPTIC ULCER DRUGS INDUSTRY ASSESSMENTS
  • Total Anti Peptic Ulcer Drugs Sales Volume
  • Anti Peptic Ulcer Drugs Sales Volume by Drugs Classification
  • Proton Pump Inhibitors Market Share by Drugs Classification
  • H2 Receptor Antagonist Market Share by Drugs Classification
  • Gastric Mucosal Protective Drugs Market Share by Drugs Classification
  • Anti Peptic Ulcer Drugs Sales Volume

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Changzhou Siyao Pharmaceutical Co. Ltd.
  • Nanjing Aosaikang Medicinal Group